-
hcup-us.ahrq.gov/reports/race/C18RECaseStudyReportforWEBfinal99.pdf
January 01, 2020 - A non-Partner created a report about cardiovascular
health that included race/ethnicity discharge data … Policy Analysis have informed the following reports by divisions of the Department of Health:
• Cardiovascular … Two such goals are to
reduce the age-adjusted hospitalization rate for cardiovascular disease among … The Wisconsin Plan for Heart Disease and Stroke Prevention 2005-200953 is a blueprint
for improving cardiovascular … http://dhs.wisconsin.gov/Health/cardiovascular/pdf_files/WI_Plan_HeartDisease_Stroke_Prevention.pdf
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/abdominal-aortic-aneurysm-screening
December 10, 2019 - assessed with respect to all-cause mortality or AAA mortality because multicomponent screening and cardiovascular … with AAA would already be candidates for aggressive CVD risk management based on the Atherosclerotic Cardiovascular … disease events: 10-year follow-up data from the Cardiovascular Health Study. … Treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: synopsis … Statin use for the primary prevention of cardiovascular disease in adults: US Preventive Services Task
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary43/prostate-cancer-screening-2012
October 07, 2011 - Prostatectomy was associated with perioperative death (about 0.5%) and cardiovascular events (0.6% to … In the Medicare database study, perioperative rates of serious cardiovascular events were 3% and rates … In 2 other studies ( n =1243 63 and 11,010 59 ), rates of cardiovascular events were 0.6% and 3% and … Prostatectomy was also associated with perioperative (30-day) mortality (about 0.5%) and cardiovascular … Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer.
-
cds.ahrq.gov/sites/default/files/workgroups/221/feb-2017-cholesterol-wg-notes.docx
January 01, 2017 - representation and constraints for certain data elements used to calculate the 10-year risk of atherosclerotic cardiovascular
-
cds.ahrq.gov/sites/default/files/workgroups/71451/CDS_Connect_WG_March_2022_Summary.pdf
January 01, 2022 - Services Task Force (USPSTF) aspirin prescribing guidelines for preventing colorectal cancer and
cardiovascular
-
www.ahrq.gov/sites/default/files/wysiwyg/patients-consumers/prevention/lifestyle/women-over-50.pdf
March 01, 2014 - Overweight and
obesity can lead to diabetes and cardiovascular
disease.
-
www.ahrq.gov/sites/default/files/wysiwyg/patients-consumers/patient-involvement/healthy-men/healthy-men.pdf
March 01, 2014 - Overweight and
obesity can lead to diabetes and cardiovascular
disease.
-
psnet.ahrq.gov/node/49671/psn-pdf
November 01, 2012 - Guidelines developed in collaboration with the American Academy of
Family Physicians, Society for Cardiovascular
-
www.ahrq.gov/patient-safety/settings/long-term-care/resource/injuries/fallspx/man3.html
December 01, 2017 - For residents with complaints of dizziness or lightheadedness, history of recurrent falls or use of cardiovascular
-
www.ahrq.gov/sites/default/files/wysiwyg/takeheart/training/event-summary-leveraging-data-enhance-cr-program.pdf
November 12, 2020 - Employee Fitness, CHI – Memorial Hospital, Chattanooga, TN
• Julianne DeAngelis, MS CCRP, CEP, Lifespan Cardiovascular
-
www.ahrq.gov/research/findings/nhqrdr/chartbooks/blackhealth/part3-nqs.html
March 01, 2016 - of the Heckler Report—Care for Cancer
Part 2: Trends in Priorities of the Heckler Report—Care for Cardiovascular
-
www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/brca-related-cancer-risk-assessment-genetic-counseling-testing
January 18, 2024 - results, overdiagnosis, overtreatment, and nonadherence); risk-reducing medications (thromboembolic and cardiovascular
-
digital.ahrq.gov/ahrq-funded-projects/evaluation-computerized-clinical-decision-support-system-and-electronic-health
January 01, 2023 - affects millions of adults in the United States (US) and is the most prevalent modifiable risk factor for cardiovascular
-
hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2022_CORE.PDF
January 01, 2022 - CVASC PROC WITH DRUG-ELUTING STENT WITH MCC OR 4+ ARTERIES OR STENTS 54,910 0.33%
246: PERCUTANEOUS CARDIOVASCULAR … 214 0.00%
249: PERC CVASC PROC WITH NON-DRUG-ELUTING STENT WITHOUT MCC 928 0.01%
249: PERCUTANEOUS CARDIOVASCULAR … 0.01%
251: PERC CVASC PROC WITHOUT CORONARY ARTERY STENT WITHOUT MCC 4,530 0.03%
251: PERCUTANEOUS CARDIOVASCULAR … PROCEDURES WITH MCC 28,194 0.17%
271: OTHER MAJOR CARDIOVASCULAR PROCEDURES WITH CC 23,047 0.14%
272 … : OTHER MAJOR CARDIOVASCULAR PROCEDURES WITHOUT CC/MCC 8,268 0.05%
273: PERCUTANEOUS AND OTHER INTRACARDIAC
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-opioid-chronic-pain-surveillance-report-3.xlsx
September 30, 2015 - Inclusion: Patients diagnosed with rheumatoid arthritis
Exclusion: Patients with previous major adverse cardiovascular … B
Major adverse cardiovascular events: 52 vs. 72
Incidence rate per 10,000 person months (95% CI): 30.12 … Control; CI = confidence interval; CI = comorbidity index; CPT = Current Procedural Terminology; CV = cardiovascular
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/human-immunodeficiency-virus-hiv-infection-screening-2005
July 05, 2005 - events associated with HAART, including metabolic disturbances associated with an increased risk for cardiovascular … hyperlipidemia and diabetes) related to HAART regimens have been associated with an increased incidence of cardiovascular … exposure. 37 The estimated 3-year benefits of HAART regimens appear, however, to greatly outweigh the cardiovascular
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/KWfaboZAt9KKoDMQbLvbbt
June 20, 2019 - events associated with HAART, including metabolic distur-
bances associated with an increased risk for cardiovascular … hyperlipidemia and diabetes)
related to HAART regimens have been associated with an
increased incidence of cardiovascular … The estimated 3-year benefits of
HAART regimens appear, however, to greatly outweigh
the cardiovascular
-
www.ahrq.gov/sites/default/files/wysiwyg/research/findings/ta/topicrefinement/afib_topicref.pdf
January 01, 2020 - cognition, functional status
and other patient-reported outcomes
• Hospitalization/readmission for
cardiovascular … adverse events (procedure or
treatment related)
• In-hospital and 30-day mortality (all-cause,
cardiovascular … Prevalence of atrial fibrillation in elderly subjects
(the Cardiovascular Health Study).
-
hcup-us.ahrq.gov/reports/methods/2011_02.pdf
January 01, 2011 - and 17.3% of all CPT based
procedures, and the top five Digestive, Integumentary, Musculoskeletal, Cardiovascular … For hospital-based facilities, Integumentary System, Musculoskeletal
System, Cardiovascular System, … 1.4%
Male Genital System 20,968 1.0% 33,611 0.7%
Invalid or Inconsistent** 17,863 0.9% 104,381 2.1%
Cardiovascular … ) 0.0%
8 9 9: Other OR therapeutic nervous system procedures 0.0%
9 63 63: Other non-OR therapeutic cardiovascular … System (43-63)
Cardiovascular
System (43-63)
Heme and
Lymphatic
System (64-67)
Heme and
-
hcup-us.ahrq.gov/db/nation/neds/stats/NEDS_2018_IP_MaskedStats.PDF
January 01, 2018 - PACEMAKER IMPLANT W/O CC/MCC 5,291 0.10
245: AICD GENERATOR PROCEDURES 857 0.02
246: PERCUTANEOUS CARDIOVASCULAR … PROCEDURES W MCC 7,078 0.14
271: OTHER MAJOR CARDIOVASCULAR PROCEDURES W CC 4,497 0.09
272: OTHER … MAJOR CARDIOVASCULAR PROCEDURES W/O CC/MCC 1,262 0.02
273: PERCUTANEOUS INTRACARDIAC PROCEDURES W MCC … PROCEDURES W MCC 7,085 0.14
271: OTHER MAJOR CARDIOVASCULAR PROCEDURES W CC 4,493 0.09
272: OTHER … MAJOR CARDIOVASCULAR PROCEDURES W/O CC/MCC 1,262 0.02
273: PERCUTANEOUS INTRACARDIAC PROCEDURES W MCC